T2 Biosystems Company Profile (NASDAQ:TTOO)

About T2 Biosystems

T2 Biosystems logoT2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TTOO
  • CUSIP:
Key Metrics:
  • Previous Close: $6.01
  • 50 Day Moving Average: $5.52
  • 200 Day Moving Average: $6.22
  • 52-Week Range: $4.89 - $11.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.46
  • P/E Growth: 0.00
  • Market Cap: $176.20M
  • Outstanding Shares: 30,431,000
  • Beta: 1.64
Profitability:
  • Net Margins: -1,250.59%
  • Return on Equity: -134.73%
  • Return on Assets: -65.41%
Debt:
  • Debt-to-Equity Ratio: 0.44%
  • Current Ratio: 4.20%
  • Quick Ratio: 4.13%
Additional Links:
Companies Related to T2 Biosystems:

Analyst Ratings

Consensus Ratings for T2 Biosystems (NASDAQ:TTOO) (?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $7.40 (27.81% upside)

Analysts' Ratings History for T2 Biosystems (NASDAQ:TTOO)
Show:
DateFirmActionRatingPrice TargetDetails
2/14/2017Canaccord GenuitySet Price TargetBuy$9.00View Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$7.00View Rating Details
2/5/2017WBB SecuritiesReiterated RatingBuy$12.00View Rating Details
11/10/2016Leerink SwannReiterated RatingMarket Perform$5.00View Rating Details
7/9/2016Janney Montgomery ScottReiterated RatingHoldView Rating Details
7/8/2016BTIG ResearchDowngradeBuy -> Sell$12.00 -> $4.00View Rating Details
5/2/2016Morgan StanleyReiterated RatingHoldView Rating Details
12/22/2015Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$13.00 -> $14.00View Rating Details
11/3/2015Jefferies Group LLCReiterated RatingBuy -> Fair Value$21.00 -> $11.48View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for T2 Biosystems (NASDAQ:TTOO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2017        
11/1/2016Q3($0.52)($0.51)$2.03 million$1.08 millionViewN/AView Earnings Details
8/1/2016Q2($0.56)($0.58)$1.53 million$0.99 millionViewN/AView Earnings Details
5/2/2016Q1($0.54)($0.55)$1.10 millionViewN/AView Earnings Details
2/16/2016Q4($0.59)($0.56)$1.21 million$1.01 millionViewListenView Earnings Details
11/2/2015Q3($0.59)($0.57)$0.66 million$1.05 millionViewN/AView Earnings Details
8/4/2015Q215($0.57)($0.54)$0.34 million$0.56 millionViewN/AView Earnings Details
5/5/2015Q115($0.57)($0.53)$0.22 million$0.19 millionViewN/AView Earnings Details
2/17/2015Q414($0.44)($0.45)ViewN/AView Earnings Details
11/4/2014Q314($0.58)($0.71)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for T2 Biosystems (NASDAQ:TTOO)
Current Year EPS Consensus Estimate: $-1.59 EPS
Next Year EPS Consensus Estimate: $-1.06 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.59)($0.55)($0.57)
Q2 20163($0.57)($0.54)($0.55)
Q3 20163($0.53)($0.52)($0.53)
Q4 20161($0.52)($0.52)($0.52)
Q1 20171($0.59)($0.59)($0.59)
Q2 20171($0.59)($0.59)($0.59)
Q3 20171($0.57)($0.57)($0.57)
Q4 20171($0.56)($0.56)($0.56)
Q1 20181($0.54)($0.54)($0.54)
Q2 20181($0.54)($0.54)($0.54)
Q3 20181($0.51)($0.51)($0.51)
Q4 20181($0.47)($0.47)($0.47)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for T2 Biosystems (NASDAQ:TTOO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for T2 Biosystems (NASDAQ:TTOO)
Insider Ownership Percentage: 43.20%
Institutional Ownership Percentage: 68.08%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/30/2016Rahul DhandaSVPSell3,589$8.16$29,286.24View SEC Filing  
3/16/2016Rahul DhandaSVPSell7,588$8.01$60,779.88View SEC Filing  
12/9/2015Aisling Capital Iii LpMajor ShareholderBuy307,692$9.75$2,999,997.00View SEC Filing  
12/9/2015David B ElsbreeDirectorBuy10,000$9.75$97,500.00View SEC Filing  
7/24/2015Polaris Venture Partners V, L.Major ShareholderSell15,399$15.04$231,600.96View SEC Filing  
7/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.22$228,284.78View SEC Filing  
7/21/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$15.42$231,284.58View SEC Filing  
7/20/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.05$240,733.95View SEC Filing  
7/17/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.26$731,651.22View SEC Filing  
7/14/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$16.57$497,066.86View SEC Filing  
7/10/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.25$731,201.25View SEC Filing  
7/10/2015Thomas J LoweryInsiderSell2,000$16.03$32,060.00View SEC Filing  
7/7/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$15.91$715,902.27View SEC Filing  
7/1/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$16.09$724,001.73View SEC Filing  
6/30/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.22$243,283.78View SEC Filing  
6/29/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$16.28$244,183.72View SEC Filing  
6/26/2015Polaris Venture Partners V, L.Major ShareholderSell44,997$17.08$768,548.76View SEC Filing  
6/23/2015Polaris Venture Partners V, L.Major ShareholderSell29,998$18.18$545,363.64View SEC Filing  
6/22/2015Polaris Venture Partners V, L.Major ShareholderSell14,999$18.22$273,281.78View SEC Filing  
6/18/2015Thomas J LoweryInsiderSell1,000$18.65$18,650.00View SEC Filing  
6/12/2015Michael J CimaDirectorBuy1,000$18.91$18,910.00View SEC Filing  
6/12/2015Thomas J LoweryInsiderSell1,471$18.55$27,287.05View SEC Filing  
5/8/2015Michael A PfallerInsiderSell15,440$16.31$251,826.40View SEC Filing  
4/20/2015Thomas J LoweryInsiderSell1,000$18.43$18,430.00View SEC Filing  
3/4/2015David B ElsbreeDirectorBuy1,450$15.05$21,822.50View SEC Filing  
11/13/2014David B ElsbreeDirectorBuy1,500$14.75$22,125.00View SEC Filing  
8/12/2014Aisling Capital Iii LpMajor ShareholderBuy454,545$11.00$4,999,995.00View SEC Filing  
8/12/2014Sarah O KalilCOOBuy15,000$11.00$165,000.00View SEC Filing  
8/12/2014Thomas J CarellaDirectorBuy909,090$11.00$9,999,990.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for T2 Biosystems (NASDAQ:TTOO)
DateHeadline
News IconInvestor Watch: Checking in on Shares of T2 Biosystems, Inc. (NASDAQ:TTOO) - Midway Monitor (NASDAQ:TTOO)
midwaymonitor.com - February 22 at 9:33 PM
News IconT2 Biosystems Inc TTOO Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:TTOO)
www.bioportfolio.com - February 17 at 6:54 PM
News IconT2 Biosystems Inc TTOO Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250 (NASDAQ:TTOO)
www.bioportfolio.com - February 16 at 8:15 PM
News IconT2 Biosystems Inc TTOO Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250 (NASDAQ:TTOO)
www.bioportfolio.com - February 16 at 8:15 PM
biz.yahoo.com logoT2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:TTOO)
biz.yahoo.com - February 16 at 8:14 PM
biz.yahoo.com logoT2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:TTOO)
biz.yahoo.com - February 16 at 8:14 PM
News IconEPS of $-0.45 Anticipated For T2 Biosystems, Inc. (NASDAQ:TTOO) - Aiken Advocate (NASDAQ:TTOO)
aikenadvocate.com - February 14 at 6:41 AM
News IconT2 Biosystems, Inc. (TTOO) investors have generally offloaded the ... - Post Analyst (NASDAQ:TTOO)
postanalyst.com - February 14 at 6:41 AM
globenewswire.com logoT2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results - GlobeNewswire (press release) (NASDAQ:TTOO)
globenewswire.com - February 14 at 6:41 AM
finance.yahoo.com logoEdited Transcript of TTOO earnings conference call or presentation 13-Feb-17 9:30pm GMT (NASDAQ:TTOO)
finance.yahoo.com - February 14 at 6:41 AM
finance.yahoo.com logoT2 Biosystems to Present at the Leerink Global Healthcare Conference (NASDAQ:TTOO)
finance.yahoo.com - February 6 at 11:02 PM
News IconStudy highlights rapid detection of platelet function using T2MR technology (NASDAQ:TTOO)
www.dotmed.com - February 3 at 6:25 AM
News IconAverage Directional Index in Review for T2 Biosystems Inc. (TTOO) - Sherwood Daily (NASDAQ:TTOO)
sherwooddaily.com - February 2 at 6:13 AM
us.rd.yahoo.com logoStudy Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology (NASDAQ:TTOO)
us.rd.yahoo.com - January 30 at 10:49 AM
News IconT2 Biosystems Inc TTOO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:TTOO)
www.bioportfolio.com - January 29 at 11:05 PM
feeds.benzinga.com logoT2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship (NASDAQ:TTOO)
feeds.benzinga.com - January 25 at 7:01 AM
News IconMarket Review: Indicator Watch for T2 Biosystems Inc. (TTOO) - Sherwood Daily (NASDAQ:TTOO)
sherwooddaily.com - January 24 at 8:05 AM
News IconConsensus Take: T2 Biosystems, Inc. (NASDAQ:TTOO) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:TTOO)
aikenadvocate.com - January 24 at 8:05 AM
4-traders.com logoSolar Capital : Stake Held by Polar Capital Llp (NASDAQ:TTOO)
www.4-traders.com - January 21 at 8:09 PM
biz.yahoo.com logoT2 BIOSYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TTOO)
biz.yahoo.com - January 21 at 4:33 AM
News IconStock Sees Muffled Start to the Session Gapping Down: T2 Biosystems, Inc. (NASDAQ:TTOO) - Aiken Advocate (NASDAQ:TTOO)
aikenadvocate.com - January 20 at 7:20 AM
News IconWhat are Analysts Expecting for T2 Biosystems, Inc. (NASDAQ:TTOO) Earnings? - Aiken Advocate (NASDAQ:TTOO)
aikenadvocate.com - January 16 at 8:08 PM
realistinvestor.com logoT2 Biosystems, Inc. (NASDAQ:TTOO) Analysts Rating At 2 - RealistInvestor.com (NASDAQ:TTOO)
www.realistinvestor.com - January 15 at 7:48 PM
News IconWill The Needle Move For T2 Biosystems, Inc. (NASDAQ:TTOO) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:TTOO)
wsbeacon.com - January 14 at 6:41 AM
marketexclusive.com logoT2 BIOSYSTEMS,INC. (NASDAQ:TTOO) Files An 8-K Results of Operations and Financial Condition - Market Exclusive (NASDAQ:TTOO)
marketexclusive.com - January 12 at 6:00 AM
News IconStock Reaching Most Volatile List Today: T2 Biosystems, Inc. (NASDAQ:TTOO) - Wall Street Beacon (NASDAQ:TTOO)
wsbeacon.com - January 12 at 6:00 AM
marketexclusive.com logoT2 BIOSYSTEMS,INC. (NASDAQ:TTOO) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:TTOO)
marketexclusive.com - January 10 at 2:56 AM
us.rd.yahoo.com logoT2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress (NASDAQ:TTOO)
us.rd.yahoo.com - January 10 at 2:56 AM
us.rd.yahoo.com logo6:31 am T2 Biosystems announced preliminary results for Q4; on track to meet or exceed commercial guidance and regulatory timelines (NASDAQ:TTOO)
us.rd.yahoo.com - January 10 at 2:56 AM
biz.yahoo.com logoT2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit (NASDAQ:TTOO)
biz.yahoo.com - January 7 at 6:12 AM
streetinsider.com logoT2 Biosystems (TTOO) Enters $50M Credit Facility (NASDAQ:TTOO)
www.streetinsider.com - January 5 at 7:17 AM
finance.yahoo.com logo6:31 am T2 Biosystems enters into a $50 mln debt facility agreement with CRG LP (NASDAQ:TTOO)
finance.yahoo.com - January 5 at 7:17 AM
publicnow.com logoT2 Biosystems, Inc. Announces $50M Credit Facility (NASDAQ:TTOO)
www.publicnow.com - January 5 at 7:17 AM
capitalcube.com logoETFs with exposure to T2 Biosystems, Inc. : December 19, 2016 (NASDAQ:TTOO)
us.rd.yahoo.com - December 20 at 4:58 PM
News IconChart Trading: Viewing CCI and ADX Levels for T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - December 16 at 6:08 AM
News IconInvestor Corner: Checking the Charts for T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - December 15 at 6:53 AM
News IconBroker Changes For T2 Biosystems, Inc. (TTOO) - NewsDen (NASDAQ:TTOO)
newsden.net - December 14 at 6:59 AM
News IconShares Drop to Low Point for the Year: T2 Biosystems, Inc. (NASDAQ:TTOO) - Prospect Journal (NASDAQ:TTOO)
prospectjournal.com - December 14 at 6:59 AM
News IconTrading Radar: Checking Technicals for T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - December 14 at 6:59 AM
capitalcube.com logoETFs with exposure to T2 Biosystems, Inc. : December 8, 2016 (NASDAQ:TTOO)
www.capitalcube.com - December 9 at 1:52 AM
News IconNarrowing in on Trading Indicators for T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - December 7 at 12:59 AM
News IconChecking Share Average and RSI Levels on T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - December 3 at 9:45 AM
News IconWatching the Technicals on Shares of T2 Biosystems Inc. (TTOO) - Yankee Analysts (NASDAQ:TTOO)
yankeeanalysts.com - November 30 at 10:13 AM
News IconFCF Score and Price Index Look on Shares of T2 Biosystems, Inc. (NASDAQ:TTOO) - Marion Business Daily (NASDAQ:TTOO)
marionbusinessdaily.com - November 28 at 8:30 AM
News IconT2 Biosystems, Inc. TTOO Product Pipeline Analysis, 2016 Update Prices from USD $750 (NASDAQ:TTOO)
www.bioportfolio.com - November 24 at 11:25 AM
News IconInvestor Watch: Checking in on Shares of T2 Biosystems, Inc. (NASDAQ:TTOO) - Wall Street Lion (NASDAQ:TTOO)
wslnews.com - November 21 at 8:34 PM
News IconTechnical Watch on These Shares: T2 Biosystems Inc. (TTOO) - MicroCap Wired (NASDAQ:TTOO)
www.microcapwired.com - November 21 at 8:34 PM
News IconT2 Biosystems, Inc. TTOO Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:TTOO)
www.bioportfolio.com - November 20 at 7:36 PM
News IconChart Focus: Eye on Technicals for T2 Biosystems Inc. (TTOO) - MicroCap Wired (NASDAQ:TTOO)
www.microcapwired.com - November 18 at 11:31 AM
finance.yahoo.com logoT2 BIOSYSTEMS, INC. Financials (NASDAQ:TTOO)
finance.yahoo.com - November 17 at 7:44 PM

Social

What is T2 Biosystems' stock symbol?

T2 Biosystems trades on the NASDAQ under the ticker symbol "TTOO."

Where is T2 Biosystems' stock going? Where will T2 Biosystems' stock price be in 2017?

7 equities research analysts have issued twelve-month price targets for T2 Biosystems' stock. Their forecasts range from $4.00 to $12.00. On average, they expect T2 Biosystems' stock price to reach $7.40 in the next year.

When will T2 Biosystems announce their earnings?

T2 Biosystems is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

What are analysts saying about T2 Biosystems stock?

Here are some recent quotes from research analysts about T2 Biosystems stock:

  • WBB Securities analysts commented, "We Believe that in the not too distant future, doctors in residency will be trained to detect fungal and bacterial infections in hours with 95% accuracy versus the current blood culture standard of two days on average for invasive candidiasis detection, with 38% accuracy. This is the special province that T2 Biosystems, Inc. (TTOO) presently dominates. We are therefore reiterating our Strong Buy Rating and 12-Month Price Target of $12.00." (2/5/2017)

  • According to Zacks Investment Research, "T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. " (1/11/2017)

Who owns T2 Biosystems stock?

T2 Biosystems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (0.64%). Company insiders that own T2 Biosystems stock include Aisling Capital Iii Lp, David B Elsbree, Michael A Pfaller, Michael J Cima, Polaris Venture Partners V, L, Rahul Dhanda and Thomas J Lowery.

Who bought T2 Biosystems stock? Who is buying T2 Biosystems stock?

T2 Biosystems' stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp. Company insiders that have bought T2 Biosystems stock in the last two years include Aisling Capital Iii Lp, David B Elsbree and Michael J Cima.

How do I buy T2 Biosystems stock?

Shares of T2 Biosystems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of T2 Biosystems stock cost?

One share of T2 Biosystems stock can currently be purchased for approximately $5.79.

T2 Biosystems (NASDAQ:TTOO) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for T2 Biosystems (NASDAQ:TTOO)

Earnings History Chart

Earnings by Quarter for T2 Biosystems (NASDAQ:TTOO)

Dividend History Chart

Dividend Payments by Quarter for T2 Biosystems (NASDAQ:TTOO)

Last Updated on 2/23/2017 by MarketBeat.com Staff